|
09 Mar 2007 |
La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent Lupus Phase 3 Trial
|
|
07 Mar 2007 |
ProNAi and Novosom AG Announce Collaboration to Enable Delivery of DNAi-based Cancer Therapeutics
|
|
02 Mar 2007 |
AVI BioPharma Presents Novel HIV Drug Candidate Results
|
|
01 Mar 2007 |
IDM Pharma Announces the Completion of Enrollment in Two Phase II Trials of Uvidem(R) in Melanoma
|
|
01 Mar 2007 |
Amsterdam Molecular Therapeutics BV receives global rights to develop and commercialize AMT-020 for acute intermittent porphyria
|
|
24 Feb 2007 |
Phase 2 Results of Genasense(R) Plus Chemotherapy in Advanced Prostate Cancer Reported at Cancer Conference
|
|
21 Feb 2007 |
Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
|
|
20 Feb 2007 |
Skin graft substitute (ICX-SKN) commences Phase I
|
|
15 Feb 2007 |
Aastrom's U.S. Clinical Investigator to Report Interim Data on Long Bone Fracture Repair Trial
|
|
15 Feb 2007 |
BrainStorm Cell Therapeutics Initiates Stem Cell Safety Study in Primates for Parkinson's Disease
|
|
14 Feb 2007 |
Neuralstem Inc. Cells Survive and Become Neurons in Rats With Spinal Injuries, Study Reports
|
|
14 Feb 2007 |
Osiris Announces Top-Line Interim Results for Stem Cell Trial for Knee Repair
|
|
13 Feb 2007 |
Targeted Genetics Provides Inflammatory Arthritis Clinical Trial Update
|
|
09 Feb 2007 |
Pluristem Announces US FDA Acceptance of its Pre-IND Application to begin Pre-clinical Studies using PLX- I in Hematological Malignancies
|
|
07 Feb 2007 |
Genta Announces the Company Will Appeal FDA Action on New Drug Application of Genasense(R) in Chronic Lymphocytic Leukemia
|
|
07 Feb 2007 |
ViaCell Announces CB001 Phase I Results
|
|
06 Feb 2007 |
Antisense Therapeutics Extends its Drug Discovery and Development Collaboration with Isis Pharmaceuticals
|
|
06 Feb 2007 |
SR Pharma Plc Announces Start of Phase I Trial With Novel RNAi Therapeutic RTP-801i in Age-Related Macular Degeneration (AMD)
|
|
03 Feb 2007 |
Genta Completes Response to EMEA List of Outstanding Issues for Genasense® Marketing Authorization Application in Melanoma
|
|
02 Feb 2007 |
Alnylam Presents Pre-clinical Results from Hypercholesterolemia, Huntington's Disease and Neuropathic Pain Programs at Keystone Symposium on RNAi
|
|
30 Jan 2007 |
LCT to start clinical trial of type 1 diabetes treatment
|
|
30 Jan 2007 |
Advanced Viral Begins Phase II Dermatological Study
|
|
26 Jan 2007 |
Enzon Receives FDA Clearance of HIF-1 alpha Investigational New Drug Application
|
|
25 Jan 2007 |
Introgen Reports that INGN 241 in Combination with Avastin(R) Results in Complete Tumor Regression
|
|
23 Jan 2007 |
iCo Therapeutics Receives FDA Clearance to Initiate Clinical Trial in Diabetic Macular Edema
|
